Antag Therapeutics
Copenhagen
About Antag Therapeutics
Antag Therapeutics is a biotechnology company developing metabolic and anti-obesity therapeutic drugs. It offers the development of peptide-based GIP receptor antagonists in order to monitor dietary-related metabolic diseases through the infusion to decrease blood flow and lipid uptake in adipose tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $50K – $100K
- Total funding: $90.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: antagtherapeutics.com
- Phone: +45 21 45 65 37
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/antag-therapeutics-71760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.